Funder: National Multiple Sclerosis Society
Due Dates: Investigator-initiated grants: currently unavailable | Late October 2026 (targeted RFA details announcement)
Funding Amounts: Award budgets and project durations are set in each funding announcement
Summary: Supports MS research addressing pathways to stop disease activity, restore function, and prevent new cases.
Key Information: Postdoctoral fellows, residents, other trainees, and individuals in mentored positions cannot apply to investigator-initiated Research Grants.
Description
The National Multiple Sclerosis Society’s Research Grants program supports investigator-initiated studies addressing questions in the Pathways to MS Cures Roadmap. Its three pathways focus on stopping MS disease activity, restoring function by reversing damage and symptoms, and ending MS by preventing new cases. Supported work includes fundamental and applied research, nonclinical and clinical studies, and projects in patient management, care, and rehabilitation.
The investigator-initiated opportunity is currently unavailable. For the 2026–2027 winter funding cycle, the Society plans a targeted request for applications on early detection and diagnosis of MS instead. This reflects its FY27–30 Strategic Plan and a focus on coordinated research investment. The Society expects to explore future investigator-initiated opportunities, with specific approaches still to be determined.
